⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2799449 | 0.87 | — | — | |
| SCHEMBL9452613 | 0.77 | ALDH1A1 (0.46) | — | |
| SCHEMBL1170388 | 0.77 | ALDH1A1 (0.46) | — | |
| SCHEMBL2802985 | 0.76 | — | — | |
| SCHEMBL1170855 | 0.75 | — | — | |
| SCHEMBL6426266 | 0.75 | — | — | |
| SCHEMBL3721133 | 0.74 | DNM1 (0.57) | — | |
| SCHEMBL11532788 | 0.74 | — | — | |
| SCHEMBL5426621 | 0.73 | — | — | |
| SCHEMBL5199027 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6337340-B1 | NERVE RELATED VISION DISORDERS AND IMPROVING VISION DISORDERS | GPI NIL HOLDINGS, INC. | 2002-01-08 | — | — | US | claimed |
| US-9518004-B2 | Reduced coenzyme Q10 derivative and method for production thereof | KANEKA CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150307440-A1 | REDUCED COENZYME Q10 DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | KANEKA CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| CN-104903289-A | Reduced coenzyme Q10 derivative and method for producing same | KANEKA CORP | 2015-09-09 | — | — | CN | disclosed |
| US-8404860-B2 | Compound having hydantoin ring and method of producing the same | TOKUYAMA CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20120289705-A1 | COMPOUND HAVING HYDANTOIN RING AND METHOD OF PRODUCING THE SAME | SHIIGI HIROFUMI (JP) | 2012-11-15 | — | — | US | disclosed |
| US-8258313-B2 | Compound having hydantoin ring and method of producing the same | TOKUYAMA CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20100184993-A1 | COMPOUND HAVING HYDANTOIN RING AND METHOD OF PRODUCING THE SAME | TOKUYAMA CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| EP-2172459-A1 | COMPOUND HAVING HYDANTOIN RING AND METHOD OF PRODUCING THE SAME | Tokuyama Corporation (JP) | 2010-04-07 | — | — | EP | disclosed |
| EP-1842845-A1 | Aza-heterocyclic compounds used to treat neurological disorders and hair loss | GliaMed, Inc. (US) | 2007-10-10 | — | — | EP | disclosed |
| CN-1295561-A | N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres | GPINTL HOLDINGS CO (US) | 2001-05-16 | — | — | CN | disclosed |
| EP-1011650-A1 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | Amgen Inc., (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-2000032588-A2 | CARBOXYLIC ACIDS AND CARBOXYLIC ACID ISOSTERES OF N-HETEROCYCLIC COMPOUNDS | GPI NIL HOLDINGS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000009103-A9 | N-LINKED SULFONAMIDES OF N-HETEROCYCLIC CARBOXYLIC ACIDS OR ISOSTERES FOR VISION AND MEMORY DISORDERS | GUILFORD PHARM INC (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000016603-A2 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL HOLDINGS, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000009102-A2 | CARBOXYLIC ACIDS AND ISOSTERES OF N-HETEROCYCLIC COMPOUNDS FOR VISION AND MEMORY DISORDERS | GPI NIL HOLDINGS, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| WO-2000009125-A1 | UREAS AND CARBAMATES OF N-HETEROCYCLIC CARBOXYLIC ACIDS AND ISOSTERES FOR VISION AND MEMORY DISORDERS | GPI NIL HOLDINGS, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| WO-1999014998-A2 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | AMGEN INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| EP-0710671-B1 | 2-Nitroalkyl ethers of native or modified starch, method for the preparation thereof, and ethers derived therefrom | AVEBE COOP VERKOOP PROD (NL) | 1999-02-10 | — | — | EP | disclosed |
| EP-0710671-A1 | 2-Nitroalkyl ethers of native or modified starch, method for the preparation thereof, and ethers derived therefrom | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. (NL) | 1996-05-08 | — | — | EP | disclosed |